Università LUM Giuseppe Degennaro - sito della Ricerca Institutional Research Information System

ROCCA, BIANCA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.550
SA - Sud America 2.328
NA - Nord America 1.827
EU - Europa 445
AF - Africa 361
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.517
Salva come PNG Salva come JPEG
Nazione #
BR - Brasile 1.840
US - Stati Uniti d'America 1.710
VN - Vietnam 978
SG - Singapore 828
CN - Cina 338
MA - Marocco 248
AR - Argentina 209
ID - Indonesia 129
DE - Germania 108
HK - Hong Kong 106
EC - Ecuador 104
IT - Italia 59
RU - Federazione Russa 56
MX - Messico 53
CO - Colombia 52
BD - Bangladesh 48
ZA - Sudafrica 48
PY - Paraguay 43
AT - Austria 42
IN - India 31
FR - Francia 30
CA - Canada 28
GB - Regno Unito 28
CL - Cile 25
VE - Venezuela 20
EG - Egitto 19
PE - Perù 18
UA - Ucraina 18
FI - Finlandia 15
ES - Italia 13
PK - Pakistan 13
KE - Kenya 12
DZ - Algeria 11
TN - Tunisia 11
UY - Uruguay 11
NL - Olanda 10
BG - Bulgaria 8
DO - Repubblica Dominicana 8
IQ - Iraq 8
KZ - Kazakistan 8
PL - Polonia 8
JP - Giappone 7
UZ - Uzbekistan 7
AL - Albania 6
BO - Bolivia 6
EE - Estonia 6
HN - Honduras 6
SE - Svezia 6
AZ - Azerbaigian 5
PA - Panama 5
AU - Australia 4
CU - Cuba 4
MD - Moldavia 4
NP - Nepal 4
SN - Senegal 4
TR - Turchia 4
AE - Emirati Arabi Uniti 3
BE - Belgio 3
BH - Bahrain 3
CH - Svizzera 3
CR - Costa Rica 3
IL - Israele 3
KR - Corea 3
KW - Kuwait 3
PH - Filippine 3
RS - Serbia 3
SA - Arabia Saudita 3
SK - Slovacchia (Repubblica Slovacca) 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
BA - Bosnia-Erzegovina 2
CG - Congo 2
GT - Guatemala 2
JM - Giamaica 2
LT - Lituania 2
MK - Macedonia 2
MY - Malesia 2
OM - Oman 2
PS - Palestinian Territory 2
PT - Portogallo 2
AO - Angola 1
BW - Botswana 1
BY - Bielorussia 1
CZ - Repubblica Ceca 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
HU - Ungheria 1
IE - Irlanda 1
IR - Iran 1
IS - Islanda 1
JO - Giordania 1
KH - Cambogia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
ML - Mali 1
QA - Qatar 1
RO - Romania 1
SC - Seychelles 1
Totale 7.512
Salva come PNG Salva come JPEG
Città #
Dallas 1.230
Ho Chi Minh City 386
Singapore 363
Hefei 228
Casablanca 225
Hanoi 179
São Paulo 154
Hong Kong 105
The Dalles 98
Rio de Janeiro 53
Haiphong 46
Ashburn 44
Curitiba 37
Guayaquil 36
Da Nang 34
Beijing 33
Munich 31
Belo Horizonte 29
Biên Hòa 29
New York 29
Quito 29
Los Angeles 28
Brasília 27
Santa Clara 26
Thái Bình 24
Hải Dương 22
Porto Alegre 22
Buenos Aires 20
Campinas 20
Ninh Bình 20
Columbus 19
Frankfurt am Main 18
Jakarta 18
Piracicaba 18
Asunción 17
Ha Long 17
Johannesburg 17
Fortaleza 15
Guarulhos 15
Sorocaba 15
Can Tho 14
Nuremberg 14
Salvador 14
Vienna 14
Bắc Giang 13
São José do Rio Preto 13
Bắc Ninh 12
Cairo 12
Viamão 12
Dhaka 11
Helsinki 11
Nairobi 11
Osasco 11
Phủ Lý 11
Ribeirão Preto 11
Thái Nguyên 11
Toronto 11
Bogotá 10
Goiânia 10
Hortolândia 10
Recife 10
Rome 10
Duque de Caxias 9
Durban 9
Itapevi 9
Manaus 9
Milan 9
Montevideo 9
Nova Friburgo 9
Rabat 9
Rio Claro 9
Sumaré 9
Surabaya 9
Bauru 8
Blumenau 8
Boston 8
Brooklyn 8
Catanduva 8
Chapecó 8
Diadema 8
Düsseldorf 8
Feira de Santana 8
Franca 8
Huế 8
Lima 8
Nova Iguaçu 8
Santos 8
Volta Redonda 8
Cape Town 7
Falkenstein 7
Indaiatuba 7
Joinville 7
Lauterbourg 7
Mauá 7
Mexico City 7
Montreal 7
Moscow 7
Niterói 7
Quảng Ninh 7
Roubaix 7
Totale 4.335
Salva come PNG Salva come JPEG
Nome #
Management of cancer-associated venous thromboembolism: Perspectives on optimizing current therapeutics with a focus on factor XI inhibition 249
Rethinking aspirin responsiveness in coronary surgery: True resistance or misinterpretation 184
2025 ESC/EACTS Guidelines for the management of valvular heart disease 150
2025 ESC/EACTS Guidelines for the management of valvular heart disease 150
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy 65
2024 EACTS Guidelines on perioperative medication in adult cardiac surgery 57
Acceptability of aspirin for cancer preventive therapy: a survey and qualitative study exploring the views of the UK general population 53
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 52
A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes 52
2024 EACTS guidelines on perioperative medication in adult cardiac surgery: embracing precision medicine driven by strong evidence-based methodology 51
Reversal of direct oral anticoagulants: guidance from the SSC of the ISTH 51
Abnormal Megakaryopoiesis and Platelet Function in Cyclooxygenase-2-Deficient Mice 51
2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS) 48
Reprogramming Epigenetic Changes Blunts p66Shc-induced Vascular Dysfunction In Experimental and Human Obesity: Insights for Mechanisms-Based Therapeutic Strategies 48
Key priorities for the implementation of the 2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes in low-resource settings 47
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 46
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes 46
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases 46
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 46
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 46
Acute, periprocedural and longterm antithrombotic therapy in older adults: 2022 Update by the ESC Working Group on Thrombosis 45
2023 ESC Guidelines for the management of acute coronary syndromes 45
Cardio-oncology: Emerging Concepts in Cardiovascular Sequelae of Cancer Therapies, Translational Research and Reverse Cardio-oncology 45
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: a joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA) 44
A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation 43
Aspirin, stroke and drug-drug interactions 43
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 43
Characterization of aspirin esterase activity in health and disease: In vitro and ex vivo studies 43
Twice Daily Dosing Normalyzes the Impaired Antiplatelet Effect of Low-Dose Aspirin Due to Enhanced Platelet Turnover in Patients Undergoing On-Pump Cardiac Surgery 43
In Vivo Platelet Activation in Impaired Glucose Tolerance and During Progression of Type 2 Diabetes: a Cross-sectional and Longitudinal Study 43
Platelet and megakaryocyte phenotypes of COX-2 deletion 43
Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspective 42
Prostaglandins and other eicosanoids 42
The lifespan determinant p66shc drives obesity-induced oxidative stress, mitochondrial dysfunction and vascular inflammation 41
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer 41
Kinetics of free platelet decrease after ADP: effect of fibrinogen binding inhibitors 40
Prolonged fasting promotes systemic inflammation and platelet activation in humans: A medically supervised, water-only fasting and refeeding study 40
A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation 40
Update on antithrombotic therapy and body mass. A Clinical consensus Statement of the ESC Working Group on Cardiovascular Pharmacotherapy and the ESC Working Group on Thrombosis 39
Clinical guidelines for a dry land: challenges in developing recommendations for DOAC management in emergent cardiac surgery 39
Effect of very long-term storage and multiple freeze and thaw cycles on 11-dehydro-thromboxane-B2 and 8-iso-prostaglandin F2α, levels in human urine samples by validated enzyme immunoassays 39
Effects of low-dose rivaroxaban combined with low-dose aspirin versus low-dose aspirin alone on in vivo platelet activation, endothelial function and inflammation in type 2 diabetes patients with stable atherosclerotic disease: the RivAsa randomized, crossover study 39
Aspirin for primary prevention: new scores for old questions? 39
2018 Joint European consensus document on the management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous cardiovascular interventions: A joint consensus document of the European Heart Rhythm Association (EHRA), European Society of Cardiology Working Group on Thrombosis, European Association of Percutaneous Cardiovascular Interventions (EAPCI), and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS), Asia-Pacific Heart Rhythm Society (APHRS), Latin America Heart Rhythm Society (LAHRS), and Cardiac Arrhythmia Society of Southern Africa (CASSA) 39
Characterization of aspirin esterase activity in health and disease: In vitro and ex vivo studies 39
Ticagrelor and Statins: Dangerous Liaisons? 38
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 38
Role of Oxidative Stress in the Pathogenesis of Atherothrombotic Diseases 37
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 37
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 37
The ESC Working Group on Cardiovascular Pharmacotherapy: continuity through transformation 37
Platelet reactivity in patients with stable cardiovascular disease using aspirin: correlation between different tests and association with subject characteristics 37
Genetic Deletion of P66 (Shc) Protects Against Obesity-Induced Mitochondrial Dysfunction, Oxidative Stress and Vascular Inflammation 37
Long-term pharmacodynamic and clinical effects of twice- versus once-daily low-dose aspirin in essential thrombocythemia: The ARES trial 37
EHA Guidelines on Management of Antithrombotic Treatments in Thrombocytopenic Patients With Cancer 36
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome 36
Heat extremes and cardiovascular diseases: a scientific statement of the Association of Cardiovascular Nursing & Allied Professions, Association for Acute Cardiovascular Care, European Association of Preventive Cardiology, Heart Failure Association, European Heart Rhythm Association of the ESC, the ESC Council on Hypertension, the ESC Council on Stroke, and the ESC Working Group on Cardiovascular Pharmacotherapy 36
Thromboxane biosynthesis and future events in diabetes: the ASCEND trial 36
Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes 36
Pathophysiology of Thrombosis in Peripheral Artery Disease 36
Impact of COX-2 deletion on platelet and megakaryocyte phenotypes 36
Obesity is associated with impaired responsiveness to once-daily low-dose aspirin and in vivo platelet activation 36
Oral anticoagulation in patients with left ventricular thrombus: a systematic review and meta-analysis 36
Platelet progenitors: the hidden drug target 35
Expression and activity of cyclooxygenase isoforms in skeletal muscles and myocardium of humans and rodents 35
Defining heparin resistance: communication from the ISTH SSC Subcommittee of Perioperative and Critical Care Thrombosis and Hemostasis 35
Antithrombotic therapy and revascularisation strategies in people with diabetes and coronary artery disease 35
The linkage between binding of C-terminal domain of hirudin and amidase activity in human alpha-thrombin 35
Highlights from the 2019 International Aspirin Foundation Scientific Conference, Rome, 28 June 2019: benefits and risks of antithrombotic therapy for cardiovascular disease prevention 35
Physiologically based modelling of the antiplatelet effect of aspirin: A tool to characterize drug responsiveness and inform precision dosing 35
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 35
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 35
Management of dyslipidaemia in patients with comorbidities—facing the challenge: type 1 diabetes mellitus 34
Directed vascular expression of the thromboxane A2 receptor results in intrauterine growth retardation 34
Nonsteroidal Antiinflammatory Drugs: Past, Present and Future 34
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector 34
Factor XI and Atrial Fibrillation: A Mismatched Pairing? 34
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: Impact on mediators and mechanisms of the inflammatory response 34
In Silico Modeling of the Antiplatelet Pharmacodynamics of Low-dose Aspirin in Health and Disease 34
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes Mellitus 34
Low-dose aspirin in polycythaemia vera: A pilot study 34
Infective Endocarditis and Antithrombotic Therapy 33
Farmaci antipiastrinici 33
Polycythemia Vera: the natural history of 1213 patients followed for 20 years 33
In vivo platelet activation and aspirin responsiveness in type 1 diabetes mellitus 33
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis 33
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 32
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: a joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 32
Management of patients on antithrombotic therapy with severe infections: a joint clinical consensus statement of the ESC Working Group on Thrombosis, the ESC Working Group on Atherosclerosis and Vascular Biology, and the International Society on Thrombosis and Haemostasis 32
Another family with IGPS 32
Prognostic significance of cyclooxygenase-2 in laryngeal squamous cell carcinoma 32
Stress-induced salivary cortisol secretion during hypobaric hypoxia challenge and in vivo urinary thromboxane production in healthy male subjects 32
The Key Contribution Of Platelet And Vascular Arachidonic Acid Metabolism To The Pathophysiology Of Atherothrombosis 31
Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis 31
Aspirin: 120 years of innovation. A report from the 2017 Scientific Conference of the International Aspirin Foundation, 14 September 2017, Charité, Berlin 31
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis 31
Fibrinogen-elongated gamma chain inhibits thrombin-induced platelet response, hindering the interaction with different receptors 31
Interindividual variability in response to aspirin and P2Y12 blockers in patients at high cardiovascular risk- the state of evidence 31
Aspirin: promise and resistance in the new millennium 31
More, More, More: Reducing Thrombosis in Acute Coronary Syndromes Beyond Dual Antiplatelet Therapy-Current Data and Future Directions 31
Totale 4.462
Salva come PNG Salva come JPEG
Categoria #
all - tutte 56.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 56.510
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20251.362 0 0 0 343 104 91 22 52 199 166 236 149
2025/20266.396 242 1.074 1.894 2.978 171 37 0 0 0 0 0 0
Totale 7.758